Sphymarine
HEALTHCARE

Intelligence Built for Healthcare Decision Makers

Navigate regulatory dynamics, track M&A activity, and monitor competitive positioning across the healthcare sector with precision intelligence.

Potential Buyers and Sellers

Identify the most likely potential buyers and targets for your projects with our proprietary data. Our AI cross-references financial performance, strategic intent, and insights across millions of documents to surface actionable M&A opportunities — giving your deal team a decisive edge.

Business Insights

Go beyond surface-level data with deep-tier intelligence on any Australian entity. Understand a company's financial health, key relationships, operations, ownership chain, and strategic positioning in minutes. Our system synthesises conventional and unconventional sources to deliver the complete picture your team needs for due diligence and advisory mandates.

New Intelligence Alerts

Stay ahead of material developments with real-time alerts on companies and industries you track. From news mentions, social media mentions, announcements to financial triggers, our alert engine continuously monitors the market and notifies you the moment something significant happens — so you never miss an event material to you and your client.

Comps

Instantly surface the most relevant comparables for any deal or advisory mandate. Our platform dynamically builds comp tables — benchmarking revenue, EBITDA, and trading multiples across peer groups — so your team can anchor valuations with precision and present deal economics with confidence.

Industry Analysis

Understand the healthcare landscape with depth and precision. Our platform maps competitive dynamics, regulatory shifts, reimbursement trends, and clinical pipeline developments across hospitals, insurers, medtech, and pharma — synthesising public filings, government data, and proprietary intelligence so your team can identify market opportunities, benchmark peers, and advise with sector-specific authority.

STAY INFORMED

Subscribe to Our Newsletter

Receive curated market intelligence, deal flow insights, and platform updates directly to your inbox.